Insider Filing: Robert Brill Receives 11,100 CVV Shares; Vests Quarterly

Rhea-AI Filing Summary

Dr. Robert M. Brill, a director of CVD Equipment Corp. (CVV), received an automatic grant of 11,100 shares of common stock on 08/08/2025 under the company’s 2022 Share Incentive Plan. The grant was issued at a $0 price and the Form reports his beneficial ownership following the grant as 46,546 shares, held directly.

The award was made pursuant to the Company’s director compensation plan at the 2025 Annual Meeting and will vest in four quarterly installments on 09/30/2025, 12/31/2025, 03/31/2026 and 06/30/2026 provided he remains a director on each vesting date. The Form 4 was signed on 08/12/2025 and was filed by one reporting person; the transaction is recorded as an acquisition (code A).

Insights

Securities Analyst

TL;DR: Director received 11,100 shares at $0 on 08/08/2025; vests quarterly and raises direct holdings to 46,546 shares.

The filing documents a routine, automatic director equity grant issued under the company’s disclosed director compensation plan and the 2022 Share Incentive Plan. The award was recorded as an acquisition on 08/08/2025 and carried a reported price of $0. After the grant, beneficial ownership is reported at 46,546 shares held directly. Vesting is contingent on continued service with quarterly vesting dates through 06/30/2026. Impact: 0 (neutral)—the filing is a standard compensation disclosure with no immediate material financial metrics reported.

Corporate Governance Expert

TL;DR: Grant governed by the 2022 Share Incentive Plan; vesting depends on continued board service across four quarterly dates.

The Form 4 states the grant was automatic following the 2025 Annual Meeting and will vest in four quarterly installments if the recipient remains a director on each vesting date. The reporting person is identified as a Director and the Form was filed by one reporting person. From a governance perspective, the disclosure documents standard director compensation mechanics and service-based vesting conditions. Impact: 0 (neutral)—informational for shareholders but not a material corporate event.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRILL DR ROBERT M

(Last) (First) (Middle)

C/O CVD EQUIPMENT CORPORATION

355 S. TECHNOLOGY DRIVE

(Street)

CENTRAL ISLIP NY 11722

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CVD EQUIPMENT CORP [ CVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/08/2025		A		11,100(1)	A	$0	46,546	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Automatic grant issued on the date of the Company's 2025 Annual Meeting of Shareholders pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan and will vest at each quarter (September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026) provided that the recipient is still serving as a Director on the respective vesting dates.

	/s/ Robert Brill	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 disclose for CVD Equipment Corp (CVV)?

The Form 4 shows Director Dr. Robert M. Brill received an automatic grant of 11,100 common shares on 08/08/2025 under the 2022 Share Incentive Plan.

How many CVV shares does Robert Brill own after the reported transaction?

Following the reported acquisition, his beneficial ownership is listed as 46,546 shares, held directly.

At what price were the CVV shares granted to the director?

The grant is reported with a price of $0 on the Form 4.

When do the granted CVV shares vest?

The grant vests in four quarterly installments on 09/30/2025, 12/31/2025, 03/31/2026 and 06/30/2026, provided the recipient remains a director on each vesting date.

When was the Form 4 signed and filed for CVV?

The signature date on the Form 4 is 08/12/2025, and the transaction date reported is 08/08/2025.